Lipitor Cholesterol Medication Antitrust Litigation

Did your U.S. business or company directly purchase Lipitor or its AB-rated bioequivalent generic products during the period of June 28, 2011 through May 28, 2012?

If so, and if you meet certain criteria, you may be entitled to compensation.

Settlement Total
Settlement Total
Eligible Purchase Dates
6/28/11 - through 5/28/12
Eligible Purchase Dates

Background Information

Direct purchasers of Lipitor, such as pharmaceutical wholesalers and distributors, allege that Pfizer conspired with Ranbaxy Laboratories Ltd. to delay the release of a cheaper generic version of Lipitor and monopolize the market. Defendants deny these allegations. The parties have reached a $93 million settlement.

Settlement Information

Filing Deadline: TBD

Settlement Class and Class Period+

All persons or entities in the United States and its territories who purchased Lipitor or its AB-rated bioequivalent generic products directly from any of the defendants at any time during the period of June 28, 2011 through May 28, 2012 (Class Period).

Excluded from the Class are the Defendants and their officers, directors, management, employees, subsidiaries, or affiliates, all federal governmental entities, and all persons or entities that (i) purchased Lipitor directly from Pfizer for the first time during the Class Period after November 30, 2011, but did not purchase generic Lipitor directly from Ranbaxy during the Class Period; and (ii) all persons or entities that purchased Lipitor directly from Pfizer after November 30, 2011 that did not also purchase generic Lipitor after November 30, 2011.

Also excluded from the Class for purposes of this Settlement Agreement are the following entities: CVS Pharmacy, Inc. (which includes Caremark), Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Walgreen Co. (which includes Kerr Drug), The Kroger Co. (which includes Peytons), Safeway Inc., SuperValu Inc., Meijer, Inc. and Meijer Distribution, Inc., Giant Eagle, Inc., and H-E-B L.P.

Case Details+

In re: Lipitor Antitrust Litigation, MDL No. 2332, Master Docket No. 3:12-cv-2389, pending in the U.S. District Court for the District of New Jersey.


Class members are not required to sign up with any third-party service in order to participate in the monetary relief, but may instead file their claim directly with the Claims Administrator. No-cost assistance will be available from the Class Administrator and Class Counsel during the claims-filing period, once established. For additional information class members may visit court approved website for this case, once established

Please note this website and its contents are not substitutes for legal advice. Nothing in this website should be construed as legal advice. Class Action Settlement House, LLC works with companies and organizations to assist them in the filing of claims in various class action settlements. However, Class Action Settlement House, LLC is not a law firm and cannot provide legal representation or legal advice. If you are seeking legal advice, please contact counsel of your choice to obtain legal advice.


Receive More Information

Receive more information on this case by completing the form below.